RELIEF srl develops UroRelief, a sterile, single‑use endourethral device that restores continence for patients with stress urinary incontinence. The silicone‑valve implant is positioned at the bladder neck via a standard outpatient endoscopic procedure under local anesthesia, requires no patient training, and is fully invisible and unisex, offering a minimally invasive alternative to existing treatments.
Funding
$1.1M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Stress urinary incontinence (SUI) affects both men and women, causing involuntary urine leakage that reduces quality of life. Current treatments often require invasive surgery, prolonged recovery, or bulky devices that are visible and uncomfortable, limiting patient compliance.
Solution
Relief offers UroRelief, a sterile, single‑use endourethral device that is positioned on the bladder neck during a standard outpatient urological procedure lasting 15–30 minutes under local anesthesia. The silicone valve mimics the external urinary sphincter, activating when the patient contracts the abdomen, thereby restoring continence without the need for permanent implants or extensive surgery. The device is unisex, fully invisible once implanted, and requires no post‑procedure training for patients. By using routine endoscopic tools, the solution can be delivered in a typical urology office, enabling rapid treatment and immediate improvement in urinary control.
Target Audience
Primary customers are urologists and urogynecologists treating patients with stress urinary incontinence, as well as healthcare facilities offering outpatient urological services.
Features
- Single‑use, sterile silicone valve that replaces the function of the external urinary sphincter
- Endourethral placement on the bladder neck via standard urological endoscopic instruments
- Outpatient procedure of 15–30 minutes performed under local anesthesia
- Unisex design: suitable for both male and female patients
- Fully invisible after implantation; no external components remain
- Minimal patient handling required; no post‑procedure training needed
- Compatible with routine urology examinations, allowing integration into existing clinical workflows